PDB9 THE VALUE OF ORAL MONOTHERAPY ALTERNATIVES IN THE FIRST-LINE TREATMENT OF TYPE-2 DIABETES MELLITUS
Nov 1, 2004, 00:00
10.1016/S1098-3015(10)65952-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)65952-9/fulltext
Title :
PDB9 THE VALUE OF ORAL MONOTHERAPY ALTERNATIVES IN THE FIRST-LINE TREATMENT OF TYPE-2 DIABETES MELLITUS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65952-9&doi=10.1016/S1098-3015(10)65952-9
First page :
Section Title :
Open access? :
No
Section Order :
318